                </a></li></ul></div><p><strong>Figure 2.  <span>MMP-8 Cleavage of LIX.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>(A) Tris-tricine 15% SDS-PAGE gel analysis of MMP-8 cleavage of murine CXCR2-binding chemokines DCIP-1, KC, LIX and MIP-2. The m/z [M+H]<sup>+</sup> of reaction products are as shown. (B) Identification of cleavage products by MALDI-TOF mass spectrometry and NH<sub>2</sub>-terminal Edman sequencing. <em>n.d.</em>, not determined. (C) Tris-tricine 15% SDS-PAGE and MALDI-TOF analysis of LIX cleavage products generated over time (h) by MMP-8. (D) Tris-tricine 15% SDS-PAGE and MALDI-TOF analysis of LIX cleavage by MMP-8 in the presence of 10-fold molar excess of recombinant hemopexin C-domain (<em>MMP-8 CD</em>), 10 µM EDTA, or 10 µM BB94. (E) Heparin Sepharose AKTA chromatograms of synthetic analogues of MMP-8 cleavage products of LIX eluted with a linear gradient of NaCl as indicated.</p>
<span>THISISTHEEND
